Condition

Hyperlipoproteinemia Type 4

Symptoms, Doctors, Treatments, Advances & More

Condition 101 About Hyperlipoproteinemia Type 4

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Top Global Doctors For Hyperlipoproteinemia Type 4

View All Doctors

Latest Advances On Hyperlipoproteinemia Type 4

Latest Advance
Study
  • Condition: Severe Hypertriglyceridemia
  • Journal: Cardiovascular diabetology
  • Treatment Used: Pemafibrate
  • Number of Patients: 3
  • Published —
This study reported on patients with severe hypertriglyceridemia (high blood triglycerides) who were treated with pemafibrate.
Latest Advance
Study
  • Condition: Familial Hypercholesterolemia
  • Journal: Thrombosis research
  • Treatment Used: PCSK-9 Inhibitors and Lipid Lowering Therapy
  • Number of Patients: 25
  • Published —
This study investigated the use of PCSK-9 inhibitors alongside lipid lowering therapy to treat patients with familial hypercholesterolemia.
View All Latest Advances

Clinical Trials For Hyperlipoproteinemia Type 4

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 100
  • Start Date: April 2021
Pragmatic Trial of Messaging to Providers About Treatment of Hyperlipidemia (PROMPT-LIPID)
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 12
  • Start Date: January 29, 2021
Two Part (Double-blind Inclisiran Versus Placebo [Year 1] Followed by Open-label Inclisiran [Year 2]) Randomized Multicenter Study to Evaluate Safety, Tolerability, and Efficacy of Inclisiran in Adolescents (12 to Less Than 18 Years) With Homozygous Familial Hypercholesterolemia and Elevated LDL-cholesterol (ORION-13)
View All Clinical Trials